Eyecarrot Innovations Corp. (OTCQB:EYCCF) (TSXV:EYC)
Breaking News
July 19, 2018
EYECARROT SECURES DISTRIBUTION
DEAL WITH AUSTRALASIA’S LEADING BEHAVIORAL OPTOMETRIC ORGANIZATION ACBO
ACBO = AUSTRALASIAN
COLLEGE OF BEHAVIOURAL OPTOMETRISTS
Toronto, Ontario --July 19, 2018 - Eyecarrot Innovations Corp.
(OTCQB:EYCCF) (TSXV:EYC)
is pleased to announce it has secured a distribution deal with the leading
Australasian Behavioural Optometric group ACBO (“The Australasian College of
Behavioural Optometrists”). Eyecarrot recently attended the 8th International
Congress of Behavioural Optometry in Sydney where the Binovi Platform was very
well received. The company will now work with ACBO to follow through on its
first shipment of 40 Binovi Touch units into the Australasian marketplace.
“ACBO has been the leading group of Behavioural Optometrists in Australasia for
many decades now and is an incredibly well-run organization. Our Binovi Platform
was incredibly well received in our recent trip to Sydney and we have
prioritized shipment of units to that region later this summer. We are excited
to be working with ACBO and the ability to extend ou r
platform globally and expect to penetrate the Australasian market with hundreds
of units”. Commented CEO Adam Cegielski.
About The Australasian College of Behavioural Optometrists
The Australasian College of Behavioural Optometrists (ACBO) was founded in 1987,
and provides Australian, New Zealand and Asian Optometrists with education and
training in behavioural optometry. Its members have special interest in
children’s vision, patients with learning difficulties, traumatic brain injury,
binocular vision dysfunction, as well as those wishing to enhance their visual
skills. ACBO is the professional association for independent optometrists who
wish to differentiate themselves by focusing on functional vision care,
neurodevelopmental optometry and vision therapy.
About Eyecarrot
Eyecarrot’s BinoviTM platform is an innovative healthcare technology solution
that integrates software, hardware, data and expert knowledge. Binovi helps
Optometrists treat vision issues with in-office therapy as well as doctor led
home based activities to better serve and increase the patient’s experience and
their therapy needs. The goal is to help transform vision performance for the 1
in 4 people worldwide that suffer from vision-related issues going beyond visual
acuity. The company is transforming how vision healthcare services are
integrated, while addressing key challenges in the health system.
On behalf of the Board of Directors
Adam Cegielski
President | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking
information" as such term is used in applicable Canadian securities laws.
Forward-looking information is based on plans, expectations, and estimates of
management at the date the information is provided and is subject to certain
factors and assumptions, including, that the Company's financial condition and
development plans do not change as a result of unforeseen events and that the
Company obtains regulatory approval. Forward-looking information is subject to a
variety of risks and uncertainties and other factors that could cause plans,
estimates and actual results to vary materially from those projected in such
forward-looking information. Factors that could cause the forward-looking
information in this news release to change or to be inaccurate include, but are
not limited to, the risk that any of the assumptions referred to prove not to be
valid or reliable, that occurrences such as those referred to above are realized
and result in delays, or cessation in planned work, that the Company's financial
condition and development plans change, and delays in regulatory approval, as
well as the other risks and uncertainties applicable to the Company as set forth
in the Company's continuous disclosure filings filed under the Company's profile
at www.sedar.com . The Company undertakes no obligation to update these
forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.
Contact:
T: +1-(416)943-6271 | +1-855-416-7158
info@eyecarrot.com
SOURCE Eyecarrot Innovations Corp
EYECARROT SECURES DISTRIBUTION
DEAL WITH BERNELL FOR 1000 BINOVI TOUCH UNITS
Toronto, Ontario --June 27, 2018 - Eyecarrot Innovations Corp.
(OTCQB:EYCCF) (TSXV:EYC)
is pleased to announce it has secured a distribution deal with the world’s
leading vision distribution organization Bernell Corporation (“Bernell”). The
first 150 units, US$450,000 revenue, will be delivered within 60 days.
Eyecarrot’s Binovi Touch Saccadic Fixator will be available through Bernell and
is showcased on the cover of their 2018 catalogue. This partnership will help
the company replace the existing 5000 analog units currently in North America.
“We are excited to secure a partnership with the leading ophthalmic distributor
for our Binovi Touch Saccadic Fixator.
After completing our initial beta testing, and now shipping our first 100 units,
we will work together with Bernell to distribute our next 1000 units into the
marketplace while expanding our reach into new markets, globally. This
represents the first of many distribution agreements which we expect to announce
in the coming months.” Commented CEO Adam Cegielski.
The Company has also granted an aggregate of 500,000 options to Directors,
Officers, Employees, and Consultants, having a two (2) year term and exercisable
at a price of $0.20 per share.
About Bernell
The Bernell Corporation was founded by Dr. Bernard Vodnoy and his wife Nellie in
1954. The company has evolved to provide over 2,000 ophthalmic products. Bernell
is proud to offer the largest assortment of Vision Training, Enhancement, and
Rehabilitation products in the world. In 2012, Bernell was presented with the
distinguished Industry Appreciation Award by the American Optometric Association
for their work and contributions to the field of Sports Vision. Bernell sells
over 2,000 ophthalmic products to optometrists, ophthalmologists, occupational
therapists, schools and government around the world. They carry a wide range of
products to meet the primary care and vision testing needs of its customers, as
well as the largest line of vision therapy, visual rehabilitation, and
behavioral optometry products in the world.
About Eyecarrot
Eyecarrot’s BinoviTM platform is an innovative healthcare technology solution
that integrates software, hardware, data and expert knowledge. Binovi helps
Optometrists treat vision issues with in-office therapy as well as doctor led
home based activities to better serve and increase the patient’s experience and
their therapy needs. The goal is to help transform vision performance for the 1
in 4 people worldwide that suffer from vision-related issues going beyond visual
acuity. The company is transforming how vision healthcare services are
integrated, while addressing key challenges in the health system.
On behalf of the Board of Directors
Adam Cegielski
President | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking
information" as such term is used in applicable Canadian securities laws.
Forward-looking information is based on plans, expectations, and estimates of
management at the date the information is provided and is subject to certain
factors and assumptions, including, that the Company's financial condition and
development plans do not change as a result of unforeseen events and that the
Company obtains regulatory approval. Forward-looking information is subject to a
variety of risks and uncertainties and other factors that could cause plans,
estimates and actual results to vary materially from those projected in such
forward-looking information. Factors that could cause the forward-looking
information in this news release to change or to be inaccurate include, but are
not limited to, the risk that any of the assumptions referred to prove not to be
valid or reliable, that occurrences such as those referred to above are realized
and result in delays, or cessation in planned work, that the Company's financial
condition and development plans change, and delays in regulatory approval, as
well as the other risks and uncertainties applicable to the Company as set forth
in the Company's continuous disclosure filings filed under the Company's profile
at www.sedar.com . The Company undertakes no obligation to update these
forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.
Contact:
T: +1-(416)943-6271 | +1-855-416-7158
info@eyecarrot.com
SOURCE Eyecarrot Innovations Corp
EYECARROT TEAMS UP WITH UC
BERKELEY, THE STATE UNIVERSITY OF NEW YORK AND FLORIDA STATE UNIVERSITY
FURTHERING THE REACH OF THE BINOVI TOUCH VISION PERFORMANCE PLATFORM
Toronto, Ontario --June 21, 2018 - Eyecarrot Innovations Corp.
(OTCQB:EYCCF) (TSXV:EYC)
is pleased to announce that it has initiated delivery of the Binovi Touch
Saccadic Fixator to some of the top Academic Institutions in North America. The
company is now working with leading vision researchers from universities in the
United States such a University of California Berkeley, The State University of
New York (SUNY), and Florida State University to accelerate use of the Binovi
Platform in developing further research in human vision performance gains.
“Our company has moved from conceptual design, to now fulfilling shipments to
World Class Institutions in the United States in under 24 months. We can now
accelerate further expansion into the market and extend the reach of our Binovi
Touch globally.” Stated CEO Adam Cegielski.
The company has now shipped 100 units of the Binovi Touch vision performance
hardware since release 2 months ago. This represents a year over year growth in
unit sales of over 500% since 2017 The company continues to receive significant
interest and increase in sales while showcasing its hardware at the 48th Annual
College of Optometrists in Vision Development Meeting.
“Recent feedback from the maret has emphasized the utility of the Binovi Touch,
as our customers are using the product every day and on every patient. We are
pleased with this increase in demand, and overall reception of our platform.
Optometrists are appreciating the expanded feature sets, their therapy teams are
embracing the modernization, and their
patients are thrilled with overall performance. Our next steps are working
towards increasing production and carrying inventory of our flagship product
with the intent of replacing the 5,000 analog models currently in the market.”
Commented CEO Adam Cegielski.
Key differentiating features of the device can be found below:
• 49 tactile responsive buttons, multi-colored button options
• 4 LED Matrix displays
• Bluetooth connectivity through the Binovi Touch mobile app
• Secure data connectivity to our Microsoft Azure API
• Modular design that allows for scaling the size of the device
• Weight of approximately 14kg (smallest and most robust in the market)
• A price point that allows for accessibility in almost any vertical market
imaginable
• Research documenting the importance of saccadic eye movements will now
increase by orders of magnitude with the release of a data connected Binovi
Touch Saccadic Fixator
About Eyecarrot
Eyecarrot’s BinoviTM platform is an innovative healthcare technology solution
that integrates software, hardware, data and expert knowledge. Binovi helps
Optometrists treat vision issues with in-office therapy as well as doctor led
home based activities to better serve and increase the patient’s experience and
their therapy needs. The goal is to help transform vision performance for the 1
in 4 people worldwide that suffer from vision-related issues going beyond visual
acuity. The company is transforming how vision healthcare services are
integrated, while addressing key challenges in the health system.
On behalf of the Board of Directors
Adam Cegielski
President | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking
information" as such term is used in applicable Canadian securities laws.
Forward-looking information is based on plans, expectations, and estimates of
management at the date the information is provided and is subject to certain
factors and assumptions, including, that the Company's financial condition and
development plans do not change as a result of unforeseen events and that the
Company obtains regulatory approval. Forward-looking information is subject to a
variety of risks and uncertainties and other factors that could cause plans,
estimates and actual results to vary materially from those projected in such
forward-looking information. Factors that could cause the forward-looking
information in this news release to change or to be inaccurate include, but are
not limited to, the risk that any of the assumptions referred to prove not to be
valid or reliable, that occurrences such as those referred to above are realized
and result in delays, or cessation in planned work, that the Company's financial
condition and development plans change, and delays in regulatory approval, as
well as the other risks and uncertainties applicable to the Company as set forth
in the Company's continuous disclosure filings filed under the Company's profile
at www.sedar.com . The Company undertakes no obligation to update these
forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.
Contact:
T: +1-(416)943-6271 | +1-855-416-7158
info@eyecarrot.com
SOURCE Eyecarrot Innovations Corp
Eyecarrot Attends 121st
American Optometric Association Meeting in Denver Colorado, to Showcase the
Binovi Touch in Sports and Performance Vision Forum
Toronto, Ontario --June 19, 2018 - Eyecarrot Innovations Corp.
(OTCQB:EYCCF) (TSXV:EYC)
is pleased to announce its participation at the 121st American Optometric
Association ("AOA") Meeting in Denver Colorado from June 20-24th. Eyecarrot will
be showcasing the recently released Binovi Touch Saccadic Fixator in the Sports
and Performance Vision Forum and will be exhibiting the Binovi Platform in the
AOA Exhibit Hall.
"We are excited to be attending our first official AOA meeting since the
development of the Binovi Platform. Our team has been working tirelessly to
introduce and sign on practices across the USA, getting invaluable market data
feedback, and working to supply the demand presented for the Binovi Touch
hardware offering. The AOA meeting will be an opportunity t o
garner further insights from the thousands of Optometrists ("O.D.) attending the
conference in Denver, and more importantly, bringing greater visibility to our
World Class Binovi Platform," commented CEO Adam Cegielski.
About the American Optometric Association
The American Optometric Association is the leading authority on quality care and
an advocate for our nation's health, representing more than 44,000 doctors of
optometry (O.D.), optometric professionals and optometry students. Doctors of
optometry take a leading role in patient care with respect to eye and vision
care, as well as general health and well-being. As primary health care
providers, doctors of optometry have extensive, ongoing training to examine,
diagnose, treat and manage ocular disorders, diseases and injuries and systemic
diseases that manifest in the eye. Doctors of optometry provide more than
two-thirds of primary eye care in the U.S.
About Eyecarrot
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution
that integrates software, hardware, data and expert knowledge. Binovi helps
Optometrists treat vision issues with in-office therapy as well as doctor led
home based activities to better serve and increase the patient's experience and
their therapy needs. The goal is to help transform vision performance for the 1
in 4 people worldwide that suffer from vision-related issues going beyond visual
acuity. The company is transforming how vision healthcare services are
integrated, while addressing key challenges in the health system.
On behalf of the Board of Directors
Adam Cegielski
President | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking
information" as such term is used in applicable Canadian securities laws.
Forward-looking information is based on plans, expectations, and estimates of
management at the date the information is provided and is subject to certain
factors and assumptions, including, that the Company's financial condition and
development plans do not change as a result of unforeseen events and that the
Company obtains regulatory approval. Forward-looking information is subject to a
variety of risks and uncertainties and other factors that could cause plans,
estimates and actual results to vary materially from those projected in such
forward-looking information. Factors that could cause the forward-looking
information in this news release to change or to be inaccurate include, but are
not limited to, the risk that any of the assumptions referred to prove not to be
valid or reliable, that occurrences such as those referred to above are realized
and result in delays, or cessation in planned work, that the Company's financial
condition and development plans change, and delays in regulatory approval, as
well as the other risks and uncertainties applicable to the Company as set forth
in the Company's continuous disclosure filings filed under the Company's profile
at www.sedar.com . The Company undertakes no obligation to update these
forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.
Contact:
T: +1-(416)943-6271 | +1-855-416-7158
info@eyecarrot.com
SOURCE Eyecarrot Innovations Corp
Eyecarrot Announces Dr. Stefan
Collier as an Advisor in Neurophotonics
Toronto, Ontario --June 12, 2018 - Eyecarrot Innovations Corp.
(OTCQB:EYCCF) (TSXV:EYC)
is pleased to announce the appointment of Dr. Stefan Collier as an Advisor in
Neurophotonics; a field of study focusing on the use of photons or quantum units
of light to study the brain and its processes at the cellular and molecular
level. Dr. Collier is one of the leading minds in his field, having completed
research in the subject going back 25 years. His previous work with the Binovi
Touch Saccadic Fixator and other Wayne Engineering Products dates back over 30
years and sets the stage for exciting future developments with Eyecarrot. Dr.
Collier has worked with professional sports for many decades, including world
class athletes at the international Tennis level and Formula 1 racing teams.
"We are very excited to continue to expand the Eyecarrot team with the
appointment of Dr. Collier. He has been recognized internationally for his
contribution to the field of Functional Syntonic Optometry, speaks 7 languages,
and will help the company in expanding the Binovi Platform globally, including
Europe" commented Adam Cegielski, Eyecarrot CEO.
"I would like to commend the company on the recently released Binovi Touch
Saccadic Fixator, the expansion of the Binovi Platform into Spain, and look
forward to working with the Eyecarrot team" stated Dr. Stefan Collier, Eyecarrot
Advisor.
About Dr. Stefan Collier, F.O., FCSO, CSO trustee, Dean BOAF
Dr. Stefan Collier is a leader in bringing functional optometry & Syntonics to
Europe. He received from OEPF the Skeffington-Alexander International Award in
2010 and the Armand Bastien Award in 2002 and 2004. He received from (CSO)
College of Syntonic Optometry the H. Riley Spitler Award in 2011. He received
from (SOE) European Society of Optometrists the SOE Award in 2009.
Additional Awards:
2012 The Lifetime Achievement Award from Behavioral Optometry Academy Foundation
BOAF
2014 The International Lifetime Achievement Award from OEPF
2015 The - Premio Robert y Linda Sanet- Award from SIODEC
2016 The Advancement of Neuro-Optometric Rehabilitation Award from NORA
About Eyecarrot
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution
that integrates software, hardware, data and expert knowledge. Binovi helps
Optometrists treat vision issues with in-office therapy as well as doctor led
home based activities to better serve and increase the patient's experience and
their therapy needs. The goal is to help transform vision performance for the 1
in 4 people worldwide that suffer from vision-related issues going beyond visual
acuity. The company is transforming how vision healthcare services are
integrated, while addressing key challenges in the health system.
On behalf of the Board of Directors
Adam Cegielski
President | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking
information" as such term is used in applicable Canadian securities laws.
Forward-looking information is based on plans, expectations, and estimates of
management at the date the information is provided and is subject to certain
factors and assumptions, including, that the Company's financial condition and
development plans do not change as a result of unforeseen events and that the
Company obtains regulatory approval. Forward-looking information is subject to a
variety of risks and uncertainties and other factors that could cause plans,
estimates and actual results to vary materially from those projected in such
forward-looking information. Factors that could cause the forward-looking
information in this news release to change or to be inaccurate include, but are
not limited to, the risk that any of the assumptions referred to prove not to be
valid or reliable, that occurrences such as those referred to above are realized
and result in delays, or cessation in planned work, that the Company's financial
condition and development plans change, and delays in regulatory approval, as
well as the other risks and uncertainties applicable to the Company as set forth
in the Company's continuous disclosure filings filed under the Company's profile
at http://www.sedar.com . The Company undertakes no obligation to update these
forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.
SOURCE Eyecarrot Innovations Corp
Eyecarrot Participates at the
48TH Annual College of Optometrists in Vision Development Meeting
Toronto, Ontario --May 31, 2018 - Eyecarrot Innovations Corp.
(OTCQB:EYCCF) (TSXV:EYC)
is pleased to announce its participation at the 48th Annual College of
Optometrists in Vision Development "COVD" Meeting held at the Hyatt Regency
Bellevue, in Bellevue, Washington. Eyecarrot was asked to educate COVD attendees
on the future of vision therapy utilizing Binovi, while showcasing the Binovi
Touch during an informative Exhibitor Seminar at the designated Eyecarrot booth.
Eyecarrot_Logo
Adam Cegielski, Eyecarrot's President and CEO Stated that "Eyecarrot, through
its Binovi Platform, echoes the mission of the COVD: to drive progress through
clinical excellence and research in developmental vision care, optometric vision
therapy, and rehabilitation. Through multiple partnerships and future
collaborations, this will result in greater education and a large adoption of
optometric vision therapy, while increasing the recognition of its integral role
in enhancing learning, productivity, and overall quality of life. We look
forward to attending additional functions throughout 2018 and 2019 to reach
clinicians across the globe and educating them on our world class platform."
About the College of Optometrists in Vision Development
The College of Optometrists in Vision Development (COVD) is a non-profit,
international membership association of eye care professionals including
optometrists, optometry students, and vision therapists. Established in 1971,
COVD provides board certification for optometrists and vision therapists who are
prepared to offer state-of-the-art services in: Behavioral and developmental
vision care, Vision therapy, and Neuro-optometric rehabilitation. These vision
care services develop and enhance visual abilities and correct many vision
problems in infants, children, and adults. Vision care provided by all COVD
members is based on the principle that vision can be developed and changed.
Their mission is to improve lives by advancing excellence in optometric vision
therapy and rehabilitation through education and board certification.
The COVD International Examination and Certification Board process includes a
rigorous evaluation of the eye care professional's knowledge and abilities in
providing developmental and behavioral vision care for patients. Optometrists
who successfully complete their certification process are Board Certified in
Vision Development and Vision Therapy and are designated Fellows of COVD (FCOVD).
Vision therapists are certified to work with COVD Fellows as Certified
Optometric Vision Therapists (COVT).
About Eyecarrot
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution
that integrates software, hardware, data and expert knowledge. Binovi helps
Optometrists treat vision issues with in-office therapy as well as doctor led
home based activities to better serve and increase the patient's experience and
their therapy needs. The goal is to help transform vision performance for the 1
in 4 people worldwide that suffer from vision-related issues going beyond visual
acuity. The company is transforming how vision healthcare services are
integrated, while addressing key challenges in the health system.
On behalf of the Board of Directors
Adam Cegielski
President | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking
information" as such term is used in applicable Canadian securities laws.
Forward-looking information is based on plans, expectations, and estimates of
management at the date the information is provided and is subject to certain
factors and assumptions, including, that the Company's financial condition and
development plans do not change as a result of unforeseen events and that the
Company obtains regulatory approval. Forward-looking information is subject to a
variety of risks and uncertainties and other factors that could cause plans,
estimates and actual results to vary materially from those projected in such
forward-looking information. Factors that could cause the forward-looking
information in this news release to change or to be inaccurate include, but are
not limited to, the risk that any of the assumptions referred to prove not to be
valid or reliable, that occurrences such as those referred to above are realized
and result in delays, or cessation in planned work, that the Company's financial
condition and development plans change, and delays in regulatory approval, as
well as the other risks and uncertainties applicable to the Company as set forth
in the Company's continuous disclosure filings filed under the Company's profile
at www.sedar.com . The Company undertakes no obligation to update these
forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.
T: (416)943-6271 l +1-855-416-7158
info@eyecarrot.com
SOURCE Eyecarrot Innovations Corp.
Eyecarrot Announces Shipment
of its First 50 Binovi Touch Saccadic Fixator Units
Toronto, Ontario --May 23, 2018 - Eyecarrot Innovations Corp.
(OTCQB:EYCCF) (TSXV:EYC)
is pleased to announce the shipment of its first 50 Binovi Touch Saccadic
Fixator units. After extensive development work, the release of the first 50
units represents a major milestone for the company. Eyecarrot showcased its
hardware recently while participating at the International Sports Vision
Association's annual show held in Utah and received feedback that helped drive
the decision to ship the Binovi Touch to market.
Eyecarrot logo
The Wayne Saccadic Fixator has been the standard in sports performance and
vision rehabilitation markets for over 40 years. With approximately 5000
traditional models currently in the market, extensive demand for the vast and
various upgraded options, the company is excited to have shipped the first
commercial units.

"We have entered into a new era of digital and connected health metrics, and we
are extremely excited to have launched our Binovi Touch Saccadic Fixator in
2018. Our development team has ensured a smooth and stable release of a device
that now improves upon 5 previous generations that go back many decades. The
team is currently overwhelmed with demand while transitioning towards a much
larger focus on commercialization," commented CEO Adam Cegielski.
Key differentiating features of the device include 49 tactile responsive
buttons, multi- coloured button options; 4 LED Matrix displays, Bluetooth
connectivity through the Binovi Touch mobile app; secure data connectivity to
our Microsoft Azure API; a modular design that allows for scaling the size of
the device; a weight of approximately 14kg (smallest and most robust in the
market); and a price point that allows for accessibility in almost any vertical
market imaginable. Research documenting the importance of saccadic eye movements
will now increase by orders of magnitude with the release of a data connected
Binovi Touch Saccadic Fixator. The company is in discussions with distributors
in North America, Europe, Africa and Asia, as well as leading researchers from
some of the best Universities in the world for a product that has unlimited
potential to aid and assist in both vision and related symptom rehabilitation as
well as vision enhancement for patients, athletes and students.
About Eyecarrot
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution
that integrates software, hardware, data and expert knowledge. Binovi helps
Optometrists treat vision issues with in-office therapy as well as doctor led
home based activities to better serve and increase the patient's experience and
their therapy needs. The goal is to help transform vision performance for the 1
in 4 people worldwide that suffer from vision-related issues going beyond visual
acuity. The company is transforming how vision healthcare services are
integrated, while addressing key challenges in the health system.
On behalf of the Board of Directors
Adam Cegielski
President | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking
information" as such term is used in applicable Canadian securities laws.
Forward-looking information is based on plans, expectations, and estimates of
management at the date the information is provided and is subject to certain
factors and assumptions, including, that the Company's financial condition and
development plans do not change as a result of unforeseen events and that the
Company obtains regulatory approval. Forward-looking information is subject to a
variety of risks and uncertainties and other factors that could cause plans,
estimates and actual results to vary materially from those projected in such
forward-looking information. Factors that could cause the forward-looking
information in this news release to change or to be inaccurate include, but are
not limited to, the risk that any of the assumptions referred to prove not to be
valid or reliable, that occurrences such as those referred to above are realized
and result in delays, or cessation in planned work, that the Company's financial
condition and development plans change, and delays in regulatory approval, as
well as the other risks and uncertainties applicable to the Company as set forth
in the Company's continuous disclosure filings filed under the Company's profile
at www.sedar.com . The Company undertakes no obligation to update these
forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.
Contact:
T: (416) 943 6271 l 1-855 416 7158
info@eyecarrot.com
SOURCE Eyecarrot Innovations Corp
EYECARROT WITH KEYNOTE SPEAKER
BRYCE SALVADOR PARTICIPATES AT THE INTERNATIONAL SPORTS VISION ASSOCIATION’S 2nd
ANNUAL SHOW
Toronto, Ontario --May 16, 2018 - Eyecarrot Innovations Corp.
(OTCQB:EYCCF) (TSXV:EYC)
is pleased to announce its participation at the International Sports Vision
Association’s 2nd annual show at the Zermatt Resort in Park City, Utah. Being a
Platinum Sponsor of the event, Eyecarrot takes great pride in being able to
contribute to such a tremendous association helping to further the importance of
sports vision science. Eyecarrot invited Bryce Salvador to contribute as the
keynote speaker of the event, relaying his personal message on the success and
importance of sports vision. This discipline is helping all types of athletes
reach higher levels of performance through the enhancement of their visual
skills. Research now validates that Athletes who use their visual system to its
maximum potential will increase overall performance, gain a competitive edge,
and decrease their likelihood of suffering from concussions in the future.

As active participants during the show, Eyecarrot was able to demonstrate early
prototypes of the Binovi Touch Saccadic Fixator with great success, receiving
positive feedback from the sports vision marketplace.
“The field of sports vision science is still in its infancy. We are now in a
time where testing, training, and most importantly data are front and centre to
what athletes have access to in terms of performance enhancing tools. With the
new Binovi Touch Saccadic Fixator, in tandem with the Binovi Touch Mobile First
Multi Platform App, Bluetooth control, and connectivity to our Microsoft Azure
API, we are significantly enhancing a tool that has been tried and tested since
the 1970s, and will now provide measurable data on many of the most important
vision skills used by athletes today” Commented CEO, Adam Cegielski.
About Special Advisor Bryce Salvador
Bryce Salvador is the former captain of the New Jersey Devils who has retired
after playing 14 seasons in the NHL. He is also the CEO of xHockey Products, one
of North America’s leading eCommerce and retailers of performance hockey
equipment, products, and training aids. Through a partnership with the Rockets
Sports Group, located in Bridgewater, NJ, Bryce looks to build a flagship center
of excellence in the Northeast for sports performance.
Bryce Salvador stated, “I am excited to be a part of the Eyecarrot Team. After a
cochlear concussion had left me sidelined for an entire hockey season, vision
therapy along with sports vision training alleviated my visual symptoms and
played a crucial role in my return to playing hockey in the NHL. Not only did
the therapy help me recover from this injury, but it also enabled me to see the
game in a way that I hadn’t before. In joining Eyecarrot, I have the opportunity
to use my first-hand experience to contribute to the development of Eyecarrot’s
high performance products for athletes and non-athletes alike”.
View Eyecarrot’s full blog on ISVA here:
https://www.eyecarrot.com/blog/eyecarrot-at-isva/
About the International Sports Vision Association
ISVA is an organization open to Optometrists, Athletic Trainers, Therapists,
Physicians, and Sports Teams. The focus of the ISVA organization is to help in
the prevention of sports vision injuries, vision enhancement therapy, prevention
and treatment of concussive injuries for athletes, contact lenses and other
eyewear options for athletes.
The mission of the International Sports Vision Academy is based on three
principles: Education, Outreach and Affiliation: Education is training
Optometrists, Vision Therapists, Athletic Trainers, Athletes and other
interested parties in the art and science of Sports Vision and the prevention of
vision-related sports injuries. Outreach is reaching Athletes, coaches,
trainers, families and other interested parties to be aware of the importance of
vision in sports and be aware of the impact of enhancement of vision skills.
Affiliation is working with other professional organizations to bring together
like-minded organizations thereby creating a more robust educational experience.
About Eyecarrot
Eyecarrot’s BinoviTM platform is an innovative healthcare technology solution
that integrates software, hardware, data and expert knowledge. Binovi helps
Optometrists treat vision issues with in-office therapy as well as doctor led
home based activities to better serve and increase the patient’s experience and
their therapy needs. The goal is to help transform vision performance for the 1
in 4 people worldwide that suffer from vision-related issues going beyond visual
acuity. The company is transforming how vision healthcare services are
integrated, while addressing key challenges in the health system.
On behalf of the Board of Directors
Adam Cegielski
President | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking
information" as such term is used in applicable Canadian securities laws.
Forward-looking information is based on plans, expectations, and estimates of
management at the date the information is provided and is subject to certain
factors and assumptions, including, that the Company's financial condition and
development plans do not change as a result of unforeseen events and that the
Company obtains regulatory approval. Forward-looking information is subject to a
variety of risks and uncertainties and other factors that could cause plans,
estimates and actual results to vary materially from those projected in such
forward-looking information. Factors that could cause the forward-looking
information in this news release to change or to be inaccurate include, but are
not limited to, the risk that any of the assumptions referred to prove not to be
valid or reliable, that occurrences such as those referred to above are realized
and result in delays, or cessation in planned work, that the Company's financial
condition and development plans change, and delays in regulatory approval, as
well as the other risks and uncertainties applicable to the Company as set forth
in the Company's continuous disclosure filings filed under the Company's profile
at www.sedar.com . The Company undertakes no obligation to update these
forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.
SOURCE Eyecarrot Innovations Corp.
Eyecarrot Announces Inclusion
Into the Tormont50
Toronto, Ontario --May 15, 2018 - Eyecarrot Innovations Corp.
(OTCQB:EYCCF) (TSXV:EYC)
is pleased to announce joining the Tormont50 upon invitation by the Tormont
Group. The Tormont 50 is a company investment platform limited to 50 companies
targeting formation of an exchange traded fund "ETF".
Companies invited to the Tormont50 must demonstrate compelling reasons for
investment, including but not limited to, undervaluation relative to peersnew
and innovative/disruptive technologies or methods, management/board evolution,
upcoming events likely to drive value appreciation which could enable an
increase in market capitalization. The Tormont50 is introduced to companies and
institutional investors providing relevant information for select top growth
opportunities identified by Tormont Group in the North American small and
microcap segment. Member companies are the upcoming new leaders in their
segment, focused on new technologies, innovation, and disruption and is limited
to a maximum of 50 Companies. Member Companies are showcased to over 60
currently subscribed institutional shareholders across North America.
"Inclusion in the Tormont50 is a testament to the work done by our team over the
last 24 months. Our Binovi Platform will help transform how we advance the human
visual system, and we are very pleased for this work to be recognized by The
Tormont Group" commented Adam Cegielski, CEO.
About The Tormont Group
The Tormont Group is a collective of corporate advisory, marketing & digital
media, and public relations experts. Their focus is assisting select companies
in presenting a succinct and uniform message to the investor community and
effectively communicating that message through the most efficient mediums
available. The Corporate Advisory partnership collectively has over 80 years of
success in portfolio management, M&A, investment banking and institutional
sales. Tormont hosts an annual Tormont50 conference in which all member
companies and institutional investors are invited. This event is an open forum
for one-on one introductions and meetings between company and interested
investors, as well as a relaxed venue for building company to company
introductions and relationships. Guest speakers will discuss topics of relevance
to the attendees and will include some of the investors subscribed to the
platform. The Tormont50 conference an exclusive event and is not be extended to
any entity outside the membership.
About Eyecarrot
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution
that integrates software, hardware, data and expert knowledge. Binovi helps
Optometrists treat vision issues with in-office therapy as well as doctor led
home based activities to better serve and increase the patient's experience and
their therapy needs. The goal is to help transform vision performance for the 1
in 4 people worldwide that suffer from vision-related issues going beyond visual
acuity. The company is transforming how vision healthcare services are
integrated, while addressing key challenges in the health system.
On behalf of the Board of Directors
Adam Cegielski
President | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking
information" as such term is used in applicable Canadian securities laws.
Forward-looking information is based on plans, expectations, and estimates of
management at the date the information is provided and is subject to certain
factors and assumptions, including, that the Company's financial condition and
development plans do not change as a result of unforeseen events and that the
Company obtains regulatory approval. Forward-looking information is subject to a
variety of risks and uncertainties and other factors that could cause plans,
estimates and actual results to vary materially from those projected in such
forward-looking information. Factors that could cause the forward-looking
information in this news release to change or to be inaccurate include, but are
not limited to, the risk that any of the assumptions referred to prove not to be
valid or reliable, that occurrences such as those referred to above are realized
and result in delays, or cessation in planned work, that the Company's financial
condition and development plans change, and delays in regulatory approval, as
well as the other risks and uncertainties applicable to the Company as set forth
in the Company's continuous disclosure filings filed under the Company's profile
at www.sedar.com . The Company undertakes no obligation to update these
forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.
Contact:
T: (416) 943 6271 l 1-855 416 7158
info@eyecarrot.com
SOURCE Eyecarrot Innovations Corp
Eyecarrot Announces Educator
Patricia Andrich as Advisor
Toronto, Ontario --May 08, 2018 - Eyecarrot Innovations Corp.
(OTCQB:EYCCF) (TSXV:EYC)
is pleased to announce the appointment of Patricia Andrich as Educational
Advisor to Eyecarrot's Binovi Platform in the development of a world class
library for advanced strategies in reflex integration. The appointment of Mrs.
Andrich to the Advisory Team demonstrates Eyecarrot's commitment to the
expansion and quality of educational material that the Binovi Platform offers.
Mrs. Andrich is a leading therapist in the field of Functional Vision
Development and will ensure the delivery of the highest quality of education
from the therapist's point of view. In addition, she will lend critical insights
to the successful implementation of Binovi into a variety of clinics worldwide.
Quote from Dr. Leonard Press about her Appointment . "I am delighted that Patti
Andrich has joined the Eyecarrot/Bino vi
family as an advisor. She brings a wealth of experience in education and
clinical practice, teaming with her spouse Dr. Alex Andrich in a highly
successful practice that revolves around vision development neuro-optometric
rehabilitation. Her presentations on primitive reflexes are highly regarded in
our field by vision therapists and optometrists, and I look forward to the
contributions that she will make to the Binovi Platform."
About Patti Andrich MA, OTR/L, COVT , INPP
Patti Andrich is an occupational therapist known for her success in treating
individuals with difficulties in visual-motor, visual-perceptual, auditory
perception and vestibular functioning. Patti received her Master degree from The
Ohio State University College of Education and her occupational therapy degree
from the Cleveland State University Department of Health Sciences. Additionally,
Patti holds certification in auditory processing using The Listening Program
with Bone Conduction from Advanced Brain Technologies and is certified in INPP
primitive reflex integration techniques; having studied in England under the
direction of Sally Goddard at the Institute of Neurological Physiological
Psychology (INPP). Patti is a certified vision therapist, member of The
Optometric Extension Program as well as the College of Optometrists in Vision
Development, the recipient of several honors and awards and has been a guest
speaker for local, state, national and international conferences.
About Eyecarrot
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution
that integrates software, hardware, data and expert knowledge. Binovi helps
Optometrists treat vision issues with in-office therapy as well as doctor led
home based activities to better serve and increase the patient's experience and
their therapy needs. The goal is to help transform vision performance for the 1
in 4 people worldwide that suffer from vision-related issues going beyond visual
acuity. The company is transforming how vision healthcare services are
integrated, while addressing key challenges in the health system.
On behalf of the Board of Directors
Adam Cegielski
President | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking
information" as such term is used in applicable Canadian securities laws.
Forward-looking information is based on plans, expectations, and estimates of
management at the date the information is provided and is subject to certain
factors and assumptions, including, that the Company's financial condition and
development plans do not change as a result of unforeseen events and that the
Company obtains regulatory approval. Forward-looking information is subject to a
variety of risks and uncertainties and other factors that could cause plans,
estimates and actual results to vary materially from those projected in such
forward-looking information. Factors that could cause the forward-looking
information in this news release to change or to be inaccurate include, but are
not limited to, the risk that any of the assumptions referred to prove not to be
valid or reliable, that occurrences such as those referred to above are realized
and result in delays, or cessation in planned work, that the Company's financial
condition and development plans change, and delays in regulatory approval, as
well as the other risks and uncertainties applicable to the Company as set forth
in the Company's continuous disclosure filings filed under the Company's profile
at http://www.sedar.com . The Company undertakes no obligation to update these
forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.
Contact:
T: +1(416)943-6271
+1-855-416-7158
info@eyecarrot.com
SOURCE Eyecarrot Innovations Corp
Eyecarrot Announces Closing Of
Financing
Toronto, Ontario --May 01, 2018 - Eyecarrot Innovations Corp.
(OTCQB:EYCCF) (TSXV:EYC)
is pleased to announce the closing of a previously announced non-brokered
private placement for total proceeds of $718,010. The Company issued a total of
4,786,733 units at $0.15 per unit, each unit comprised of one common share of
the Company (a "Share") and one transferable common share purchase warrant. Each
warrant entitles the holder to purchase one additional common share of the
Company (a "Warrant Share") until April 28th, 2020 at a purchase price of $0.30
per Warrant Share.
Aggregate finder's fees of $10,500 in cash and 70,000 finder's warrants were
paid to registrants. Each finder's warrant has the same terms as the warrants
forming part of the units, provided that the finder's warrants are
non-transferable.
All securities issued in connection with the Private Placement are subject to a
four-month hold period expiring on August
27, 2018. Further restrictions may apply to certain subscribers under foreign
securities laws.
Proceeds of the Placement are to be applied to general working capital.
About Eyecarrot
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution
that integrates software, hardware, data and expert knowledge. Binovi helps
Optometrists treat vision issues with in-office therapy as well as doctor led
home based activities to better serve and increase the patient's experience and
their therapy needs. The goal is to help transform vision performance for the 1
in 4 people worldwide that suffer from vision-related issues going beyond visual
acuity. The company is transforming how vision healthcare services are
integrated, while addressing key challenges in the health system. Eyecarrot's
objective is to help Optometrists and their teams manage a wide range of
problems involving visual function. The building of this network will
revolutionize human vision performance, and release the untapped potential of
millions of people, globally.
On behalf of the Board of Directors
Adam Cegielski
President | CEO
Telephone: 1.855.416.7158 - 416.943.6271
Forward looking information
Certain statements contained in this news release constitute "forward-looking
information" as such term is used in applicable Canadian securities laws.
Forward-looking information is based on plans, expectations, and estimates of
management at the date the information is provided and is subject to certain
factors and assumptions, including, that the Company's financial condition and
development plans do not change as a result of unforeseen events and that the
Company obtains regulatory approval. Forward-looking information is subject to a
variety of risks and uncertainties and other factors that could cause plans,
estimates and actual results to vary materially from those projected in such
forward-looking information. Factors that could cause the forward-looking
information in this news release to change or to be inaccurate include, but are
not limited to, the risk that any of the assumptions referred to prove not to be
valid or reliable, that occurrences such as those referred to above are realized
and result in delays, or cessation in planned work, that the Company's financial
condition and development plans change, and delays in regulatory approval, as
well as the other risks and uncertainties applicable to the Company as set forth
in the Company's continuous disclosure filings filed under the Company's profile
at www.sedar.com . The Company undertakes no obligation to update these
forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.
SOURCE Eyecarrot Innovations Corp
-------------------------------------------------------------------
About Eyecarrot Innovations Corp.:
We at Eyecarrot aspire for more: more for the doctor, more for the therapist,
more for the patient, and more for the benefits of Vision Therapy.
Who is Eyecarrot?
Our sight is vital in how we view the world around us. Sight and vision allow us
to connect with our surroundings, keep us safe, and helps maintain our sharpness
of mind.
Eyecarrot is focused on the importance of vision. We have made vision therapy
accessible through an improved technology that combines data, expert knowledge
and insights of vision care professionals to help patients on a global scale —
Binovi.
Binovi’s commitment will always be to maximize the collaboration between
optometrists, therapists, and patients and their education.
Our Vision
We’ve designated the Binovi platform to serve as the foundation for constructive
innovation within vision therapy. Our strategic approach sees us deliver a
collaborative care system that integrates software, hardware, data and the
expert knowledge and insights of vision care professionals.
Technology is rapidly changing the way businesses are operated, and we are
building Binovi to apply this technology to the complexities of running a modern
Vision Therapy Practice.
Our innovative platform that helps Optometrists treat vision issues with
in-office therapy as well as home based activities.
Carrots are still good for the eyes, iPads are good for Optometrists and their
teams, and over half of the world now has a smartphone and access to the
Internet. We want to use our technology to empower the world to measure,
exercise and evolve the entire Visual System – for the eyes, the brain and the
body to work together in perfect harmony.
The Challenge: What You Don’t See
The Vision Care Industry is Primarily Focused on Visual Acuity and Disease
Management.
The most commonly identified visual issues are treated with glasses, contact
lenses, surgery, or medication, leaving many visual performance issues
undiagnosed or mistreated.
There is little consideration given to options in helping advance human
performance by treating visual issues connected to learning disabilities,
amblyopia, strabismus, convergence insufficiency, brain injury and their related
conditions.
It’s time to spread the message. Vision Therapy addresses all these issues and
lets us penetrate beneath the surface. This means promise for huge gains in
human performance, improvement in recovery of brain injuries, and less reliance
on drugs to improve visual attention.
Our Solution: Binovi
A Spectrum of Possibilities.
Introducing BinoviTM from Eyecarrot — A collaborative care platform that
integrates software, hardware, data and the expert knowledge and insights of
vision care professionals.
This is the hub of your vision therapy management system. With Binovi Pro,
vision care professionals can design and manage personalized vision therapy
plans with simple, intuitive, drag-and-drop functionality. An inventory of
explicit therapy procedures with clear content and illustrative videos empowers
the therapist and patient to collaborate and communicate at an unprecedented
level both within and outside the office and practice. Binovi Coach enables
patients to manage and track their progress anywhere using their own smartphones.
We welcome you to the Eyecarrot community, and be prepared for the ride of your
professional life through the exciting Binovi platform!

Our Binovi platform works together to give Optometrists, Therapists and Patients
the type of experience they are used to receiving in the world we live in today!
We designed Binovi to help vision therapy teams move toward a paperless process
for the delivery of home therapy activities. Therapist training and education,
and the planning of weekly in-office vision therapy will streamline your
business practice. The efficiencies of digitally prescribing activities,
tracking of therapy compliance, and data capture gives insight into your
patients’ therapy, allowing you to adjust and customize therapies specific to
patient results and needs. Binovi offers you expert high-definition video
instruction to promote better education and understanding for your care teams
and patients.
With this system in place, you can design and manage personalized vision therapy
plans with simple, intuitive, drag-and-drop functionality. An inventory of
explicit therapy procedures with clear content and illustrative videos empowers
the therapist and patient to collaborate and communicate at an unprecedented
level both within and outside the office and practice.
A Purposeful and Powerful Tool for Vision Training and Vision Therapy
For Education, Sports, Healthy Aging and Rehabilitation
We have re-engineered the Wayne Saccadic Fixator —an industry standard for over
three decades to measure and improve visual memory, reaction time and peripheral
vision training— to integrate it with our Binovi platform. Currently used in
over 1,500 practices and offices in over 20 countries, the all-new Binovi Touch
is available now!
Wireless Control
Using Bluetooth wireless to sync to the Binovi Touch app, the new Binovi Touch
is easy for you to control from your iPad.
Tried-and-tested activities from the Wayne Saccadic Fixator have been ported to
the new Binovi Touch, making it easy to jump right in and start testing a number
of key vision skills right away!
Rich Insights
Best-in-class charting and data visualization give you all the power and
flexibility you need to analyze trends and progress over time.
Customizable tests can drill down into specific aspects of a patient’s vision
skills, or can be broadened to get a bigger picture of how they are progressing.
Incredible New Features
We’ve re-engineering the new Binovi Touch with new technology, allowing for a
greater range of activities.
New 49-light Array
Multi-colored lights with tactile response enable entirely new activities to
increase cognitive and visual memory load for your patients.
LED-matrix displays
All new led-matrix displays power the next generation of accomodative rock
activities for your patients
Customize and Create
Full control via Binovi Pro allows you to design custom activity sets, combining
your favourite Touch activities with physical exercise routines into
multi-disciplinary programs
Portable, Universal, Expandable
We’ve designed Binovi Touch to be as versatile as possible.
Portable
Built for endurance, yet light enough for you to carry.
Contact us for more information on recommended portable stands, mounting frames,
and to order your custom carrying case.
Universal
Powered via usb so it’s easy to use, wherever you are in the world.
The Binovi Pro app is available in multiple languages.
Expandable (coming soon)
An ever-growing range of new accessories to be used with the new Touch are under
development.
The Binovi open api integrates with certified 3rd-party devices
SOURCE: http://www.eyecarrot.com/
Disclaimer
FN Media Group LLC (FNMG) owns and operates
FinancialNewsMedia.com (FNM)
which is a third party publisher that disseminates electronic information
through multiple online media channels. FNMG's intended purposes are to deliver
market updates and news alerts issued from private and publicly trading
companies as well as providing coverage and increased awareness for companies
that issue press to the public via online newswires. FNMG and its affiliated
companies are a news dissemination and financial marketing solutions provider
and are NOT a registered broker/dealer/analyst/adviser, holds no investment
licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's
market updates, news alerts and corporate profiles are NOT a solicitation or
recommendation to buy, sell or hold securities. The material in this release is
intended to be strictly informational and is NEVER to be construed or
interpreted as research material. All readers are strongly urged to perform
research and due diligence on their own and consult a licensed financial
professional before considering any level of investing in stocks. The companies
that are discussed in this release may or may not have approved the statements
made in this release. Information in this release is derived from a variety of
sources that may or may not include the referenced company's publicly
disseminated information. The accuracy or completeness of the information is not
warranted and is only as reliable as the sources from which it was obtained.
While this information is believed to be reliable, such reliability cannot be
guaranteed. FNMG disclaims any and all liability as to the completeness or
accuracy of the information contained and any omissions of material fact in this
release. This release may contain technical inaccuracies or typographical
errors. It is strongly recommended that any purchase or sale decision be
discussed with a financial adviser, or a broker-dealer, or a member of any
financial regulatory bodies. Investment in the securities of the companies
discussed in this release is highly speculative and carries a high degree of
risk. FNMG is not liable for any investment decisions by its readers or
subscribers. Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. This release is not without bias, and
is considered a conflict of interest if compensation has been received by FNMG
for its dissemination. To comply with Section 17(b) of the Securities Act of
1933, FNMG shall always disclose any compensation it has received, or expects to
receive in the future, for the dissemination of the information found herein on
behalf of one or more of the companies mentioned in this release. For current
services performed FNMG has been compensated forty-four hundred dollars for
Eyecarrot Innovations Corp. coverage by
a non-affiliated third party. FNMG HOLDS NO SHARES OF Eyecarrot
Innovations Corp.
This release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words such as "may",
"future", "plan" or "planned", "will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in
the forward-looking statements, including the risks that actual results may
differ materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings made by such company with the
Securities and Exchange Commission. You should consider these factors in
evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and FNMG undertakes no obligation to update such
statements.
|